Senior Director
Sumitomo Pharma America Inc.
Laguna Niguel, California, United States
Health Outcomes Risk by Incremental Anticholinergic Burden in Overactive Bladder
Thursday, October 24, 2024
4:38 PM – 4:42 PM EDT
Disclosure(s): Sumitomo Pharma America Inc.: Employee (Ongoing)